108 related articles for article (PubMed ID: 14651963)
1. Regulation of the tyrosine hydroxylase gene promoter by histone deacetylase inhibitors.
Kim HS; Park JS; Hong SJ; Woo MS; Kim SY; Kim KS
Biochem Biophys Res Commun; 2003 Dec; 312(4):950-7. PubMed ID: 14651963
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
[TBL] [Abstract][Full Text] [Related]
3. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
Zhao S; Venkatasubbarao K; Li S; Freeman JW
Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
[TBL] [Abstract][Full Text] [Related]
4. Activation of the gamma-glutamyltransferase promoter 2 in the rat colon carcinoma cell line CC531 by histone deacetylase inhibitors is mediated through the Sp1 binding motif.
Mikkelsen IM; Huseby NE; Visvikis A; Moens U
Biochem Pharmacol; 2002 Jul; 64(2):307-15. PubMed ID: 12123752
[TBL] [Abstract][Full Text] [Related]
5. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.
Choi HS; Lee JH; Park JG; Lee YI
Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of potential cis-regulatory elements governing transcriptional activation of the rat tyrosine hydroxylase gene.
Yang C; Kim HS; Seo H; Kim KS
J Neurochem; 1998 Oct; 71(4):1358-68. PubMed ID: 9751166
[TBL] [Abstract][Full Text] [Related]
7. Autoregulation of mouse histone deacetylase 1 expression.
Schuettengruber B; Simboeck E; Khier H; Seiser C
Mol Cell Biol; 2003 Oct; 23(19):6993-7004. PubMed ID: 12972616
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors de-repress tyrosine hydroxylase expression in the olfactory bulb and rostral migratory stream.
Akiba Y; Cave JW; Akiba N; Langley B; Ratan RR; Baker H
Biochem Biophys Res Commun; 2010 Mar; 393(4):673-7. PubMed ID: 20170631
[TBL] [Abstract][Full Text] [Related]
9. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
Sekhavat A; Sun JM; Davie JR
Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression.
Kwon HS; Huang B; Ho Jeoung N; Wu P; Steussy CN; Harris RA
Biochim Biophys Acta; 2006; 1759(3-4):141-51. PubMed ID: 16757381
[TBL] [Abstract][Full Text] [Related]
11. Glial cell-specific regulation of the JC virus early promoter by histone deacetylase inhibitors.
Kim SY; Woo MS; Kim WK; Choi EC; Henson JW; Kim HS
J Virol; 2003 Mar; 77(6):3394-401. PubMed ID: 12610114
[TBL] [Abstract][Full Text] [Related]
12. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D
Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854
[TBL] [Abstract][Full Text] [Related]
13. Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression of CYP46A1 gene transcription.
Nunes MJ; Milagre I; Schnekenburger M; Gama MJ; Diederich M; Rodrigues E
J Neurochem; 2010 Apr; 113(2):418-31. PubMed ID: 20096088
[TBL] [Abstract][Full Text] [Related]
14. Effects of trichostatin A on neuronal mu-opioid receptor gene expression.
Lin YC; Flock KE; Cook RJ; Hunkele AJ; Loh HH; Ko JL
Brain Res; 2008 Dec; 1246():1-10. PubMed ID: 18950606
[TBL] [Abstract][Full Text] [Related]
15. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex.
Walker GE; Wilson EM; Powell D; Oh Y
Endocrinology; 2001 Sep; 142(9):3817-27. PubMed ID: 11517158
[TBL] [Abstract][Full Text] [Related]
16. CD81, a cell cycle regulator, is a novel target for histone deacetylase inhibition in glioma cells.
Gensert JM; Baranova OV; Weinstein DE; Ratan RR
Neurobiol Dis; 2007 Jun; 26(3):671-80. PubMed ID: 17481908
[TBL] [Abstract][Full Text] [Related]
17. Effects of histone deacetylase inhibitors on the Ah receptor gene promoter.
Garrison PM; Rogers JM; Brackney WR; Denison MS
Arch Biochem Biophys; 2000 Feb; 374(2):161-71. PubMed ID: 10666294
[TBL] [Abstract][Full Text] [Related]
18. Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer.
Dressel U; Renkawitz R; Baniahmad A
Anticancer Res; 2000; 20(2A):1017-22. PubMed ID: 10810390
[TBL] [Abstract][Full Text] [Related]
19. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes.
Schnur N; Seuter S; Katryniok C; Rådmark O; Steinhilber D
Biochim Biophys Acta; 2007 Oct; 1771(10):1271-82. PubMed ID: 17894944
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts.
Chen JS; Faller DV
J Cell Physiol; 2005 Jan; 202(1):87-99. PubMed ID: 15389542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
